Trial Profile
Metformin to Prevent the Metabolic Complications of Olanzapine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Olanzapine
- Indications Metabolic syndrome; Obesity
- Focus Adverse reactions; Therapeutic Use
- 17 Aug 2012 Actual end date (1 Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Sep 2010 Planned end date changed from 1 Aug 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov.